chr10-102836639-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000102.4(CYP17A1):​c.297+426G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.375 in 199,818 control chromosomes in the GnomAD database, including 14,476 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 11490 hom., cov: 30)
Exomes 𝑓: 0.34 ( 2986 hom. )

Consequence

CYP17A1
NM_000102.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.136

Publications

31 publications found
Variant links:
Genes affected
CYP17A1 (HGNC:2593): (cytochrome P450 family 17 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. It has both 17alpha-hydroxylase and 17,20-lyase activities and is a key enzyme in the steroidogenic pathway that produces progestins, mineralocorticoids, glucocorticoids, androgens, and estrogens. Mutations in this gene are associated with isolated steroid-17 alpha-hydroxylase deficiency, 17-alpha-hydroxylase/17,20-lyase deficiency, pseudohermaphroditism, and adrenal hyperplasia. [provided by RefSeq, Jul 2008]
CYP17A1 Gene-Disease associations (from GenCC):
  • congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • 46,XY disorder of sex development due to isolated 17,20-lyase deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.543 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP17A1NM_000102.4 linkc.297+426G>A intron_variant Intron 1 of 7 ENST00000369887.4 NP_000093.1 P05093Q1HB44

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP17A1ENST00000369887.4 linkc.297+426G>A intron_variant Intron 1 of 7 1 NM_000102.4 ENSP00000358903.3 P05093

Frequencies

GnomAD3 genomes
AF:
0.386
AC:
58556
AN:
151618
Hom.:
11480
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.356
Gnomad AMI
AF:
0.197
Gnomad AMR
AF:
0.392
Gnomad ASJ
AF:
0.399
Gnomad EAS
AF:
0.561
Gnomad SAS
AF:
0.350
Gnomad FIN
AF:
0.355
Gnomad MID
AF:
0.369
Gnomad NFE
AF:
0.400
Gnomad OTH
AF:
0.387
GnomAD4 exome
AF:
0.339
AC:
16289
AN:
48082
Hom.:
2986
AF XY:
0.339
AC XY:
8444
AN XY:
24922
show subpopulations
African (AFR)
AF:
0.291
AC:
473
AN:
1624
American (AMR)
AF:
0.365
AC:
1386
AN:
3798
Ashkenazi Jewish (ASJ)
AF:
0.327
AC:
356
AN:
1088
East Asian (EAS)
AF:
0.492
AC:
1374
AN:
2792
South Asian (SAS)
AF:
0.297
AC:
1787
AN:
6016
European-Finnish (FIN)
AF:
0.317
AC:
455
AN:
1436
Middle Eastern (MID)
AF:
0.311
AC:
51
AN:
164
European-Non Finnish (NFE)
AF:
0.334
AC:
9599
AN:
28728
Other (OTH)
AF:
0.332
AC:
808
AN:
2436
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
493
987
1480
1974
2467
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.386
AC:
58609
AN:
151736
Hom.:
11490
Cov.:
30
AF XY:
0.384
AC XY:
28472
AN XY:
74130
show subpopulations
African (AFR)
AF:
0.356
AC:
14708
AN:
41340
American (AMR)
AF:
0.391
AC:
5969
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.399
AC:
1383
AN:
3470
East Asian (EAS)
AF:
0.561
AC:
2881
AN:
5140
South Asian (SAS)
AF:
0.352
AC:
1692
AN:
4810
European-Finnish (FIN)
AF:
0.355
AC:
3743
AN:
10538
Middle Eastern (MID)
AF:
0.372
AC:
108
AN:
290
European-Non Finnish (NFE)
AF:
0.400
AC:
27127
AN:
67880
Other (OTH)
AF:
0.389
AC:
818
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1829
3658
5486
7315
9144
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
576
1152
1728
2304
2880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.396
Hom.:
3354
Bravo
AF:
0.390
Asia WGS
AF:
0.408
AC:
1416
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
4.1
DANN
Benign
0.45
PhyloP100
0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10786712; hg19: chr10-104596396; API